Try the modernized beta website. Learn more about the modernization effort.
Working… Menu

Efficacy and Safety of Botulinum Toxin Type A for Injection to Treat Glabellar Lines

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02303002
Recruitment Status : Completed
First Posted : November 27, 2014
Last Update Posted : March 9, 2016
Information provided by (Responsible Party):
Revance Therapeutics, Inc.